Adding growth and value stocks to your portfolio in 2016.» Read More
When it rains, it pours. I mean, what a crazy Monday for deals and data in biopharma.
As the health care debate continues, Todd Weller, health care IT analyst at Stifel Nicolaus, and Les Funtleyder, health care strategist at Miller Tabak, zero in on health care names that may bring healthy returns.
Expect the Fed to continue their purchase of Treasuries, agency debt, and mortgage-backed securities and most feel the Fed will leave the purchase programs as is and not expand the programs.
Approaching the close, the Dow has cut its losses almost in half...the five financial-oriented stocks in the Dow (B of A, Travelers, JP Morgan, AmEx, and our parent General Electric) are responsible for a negative 40 points in the Dow; but with the exception of some weakness in energy (Chevron, ExxonMobil), most other sectors are flat to down 1 percent.
President Obama probably won’t find a better way to reduce wasteful medical spending.
Opposition to the Obama administration's health care plan had a new voice Monday, as the U.S. Chamber of Commerce launched a critical ad campaign suggesting alternatives. But John Sullivan of Leerink Swann says this is a great time to buy health stocks.
The Dow Industrials briefly turned positive for the year earlier this morning. WAHOO! But wait…the S&P 500 turned positive for 2009 nearly one month ago and is now up over 4.5% this year. So why the performance lag in the Dow (compared to the S&P)?
The federal stimulus package passed in February may help some IT companies climb the stock charts. The law provides $19 billion to replace the ubiquitous paper chart on a clipboard with electronic medical records.
This year, more than any other, it looks as if the intersection between Wall Street and Main Street lies in the heart of Washington DC.
Cramer makes the call on viewers' favorite stocks.
The Lightning Round is extended in this CNBC.com exclusive feature.
The week began with a flashback to the credit crisis. It ended with figures showing the fastest inflation in six months and the lowest consumer-sentiment reading in 28 years. Along the way, as the stock market ebbed and flowed, CNBC guests assembled a collective portfolio that was heavy on technology, energy, and global exposure.
To give investors an edge, CNBC asked the market pros for their best investment advice now.
Todd Weller of Stifel Nicolaus says there's a big opportunity for investors in companies that provide information technology to giant health-care firms.
Cramer makes the call on viewers' favorite stocks.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Jacobs Engineering, Verizon, Dendreon, Rite Aid and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Hey folks, here's guest blogger Jeff Mishlove's contest picks for today: Even though my seven stock choices for Tuesday were far from my best for this contest, the first stock on my list, Champion Enterprises did quite well, gaining 8.8% in a single day. And, another top choice, Interwoven, Inc. also gained 3.9% between Tuesday’s close and Wednesday’s close.
Blogger Timothy Sykes is back with his contest picks. Here's his post: I hope everyone tuned in Friday to witness me becoming the first guest to bring female models on CNBC to show off the beauty of stock charts. The audience and the other studio guests loved it so hopefully I’ve started a new trend. We’ll see…This week’s picks are (in order of importance)...